K181817 is an FDA 510(k) clearance for the transGlideXT Expandable Introducer. Classified as Introducer, Catheter (product code DYB), Class II - Special Controls.
Submitted by Transaortic Medical, Inc. (Morgan Hill, US). The FDA issued a Cleared decision on March 26, 2019 after a review of 260 days - an extended review cycle.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.